Comprehensive Money Management Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$791K Buy
4,996
+290
+6% +$39.2K 0.5% 68
2026
Q1
$601K Hold
4,706
– – 0.39% 88
2025
Q4
$574K Buy
4,706
+160
+4% +$18.3K 0.4% 90
2025
Q3
$456K Buy
4,546
+193
+4% +$17.4K 0.32% 102
2025
Q2
$361K Sell
4,353
-289
-6% -$23.1K 0.27% 119
2025
Q1
$376K Buy
4,642
+105
+2% +$9.38K 0.3% 111
2024
Q4
$409K Buy
+4,537
New +$440K 0.34% 103

Other funds holding XBI

Comprehensive Money Management Services's XBI Position: Q2 2026 in Review

Comprehensive Money Management Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 6.2% in Q2 2026, buying an estimated $39.2K and bringing the position to 4,996 shares worth $791K. The position accounts for 0.5% of the portfolio, ranked #68.

Comprehensive Money Management Services first reported a position in XBI in Q4 2024 and has held it in 7 quarters since. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Comprehensive Money Management Services held 4,996 shares of State Street SPDR S&P Biotech ETF worth $791K as of Q2 2026.
  • Comprehensive Money Management Services bought 290 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $39.2K.
  • State Street SPDR S&P Biotech ETF made up 0.5% of Comprehensive Money Management Services's portfolio in Q2 2026, its #68 holding.
  • Comprehensive Money Management Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 7 quarters since.
  • 936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Comprehensive Money Management Services's 13F filing for Q2 2026, filed 17 Aug 2026.